News & Updates

 

Waterloo-Wellington Cardiovascular Conference

Waterloo-Wellington Cardiovascular Conference

  Family physicians (MDs) and nurse practitioners (NPs) are invited to attend the 3rd Annual Waterloo-Wellington Cardiovascular Conference, a full-day, in-person educational event focused on cardiovascular conditions relevant to primary care and community practice.   ...
Learn more about Waterloo-Wellington Cardiovascular Conference >>
Region of Waterloo Logo

Tuberculosis (TB) Reporting and Referrals

Region of Waterloo Logo
Health Care Provider Advisory Key Changes and Highlights
  • Reporting of positive TB Skin Tests (TSTs), IGRAs, and referrals to TB Clinic streamlined into a single form.
  • New Tuberculosis Preventive Treatment (TPT) ...
    Learn more about Tuberculosis (TB) Reporting and Referrals >>
  • Region of Waterloo Logo

    ISPA 2026 Update: What Providers Need to Know as School Suspensions Approach

    Region of Waterloo Logo
    Public Health is approaching key Immunization of School Pupils Act (ISPA) suspension dates for the 2026 school year. Review upcoming deadlines, suspension periods, and essential actions health care providers can take to support students and families.
    Learn more about ISPA 2026 Update: What Providers Need to Know as School Suspensions Approach >>
    conference and healthcare collaboration

    Interconnected Futures Conference: Clinical Day & Migration-Focused Programming

    conference and healthcare collaboration

    Interconnected Futures Conference

      Health care providers across Waterloo Region are invited to attend the Interconnected Futures Conference, hosted by the PEGASUS Institute. This multi-day event brings together clinicians, researchers, and global health leaders to explore the intersections of migration, health equity, ...
    Learn more about Interconnected Futures Conference: Clinical Day & Migration-Focused Programming >>

    Chikungunya Vaccine (CHIK‑LAV / IXCHIQ) – Key Safety Information

    The Ontario Ministry of Health has shared the following key information regarding the Chikungunya live attenuated vaccine (CHIK‑LAV), trade name IXCHIQ, to support awareness and vaccine safety monitoring.
    Learn more about Chikungunya Vaccine (CHIK‑LAV / IXCHIQ) – Key Safety Information >>

    Infant and High‑Risk Children RSV Prevention Program Update

    Ontario’s RSV prevention program for infants and high‑risk children has been extended into April due to ongoing community transmission across the province.  
    Learn more about Infant and High‑Risk Children RSV Prevention Program Update >>